RxDoctor Payments DataLook up a doctor →

Zemaira: payments to doctors

Payments that named Zemaira as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$482K
Providers
1,885
Transactions
3,875
Average per transaction
$124

The per-transaction average — $124 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,885 providers the average total is $256, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
CSL Behring$415,89486.3%
Vifor Pharma, Inc.$66,11613.7%
← All drugs & devices